8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
ResMed reports 6% revenue growth and raises quarterly dividend to $0.66
Filed with the SEC on · Summarized by InvestorsBot
ResMed reported fiscal Q1 2027 revenue of $1.415 billion for the quarter ended September 30, 2026, up 6% year over year, while GAAP diluted EPS rose 23% to $2.92 and non-GAAP diluted EPS increased 14% to $2.91. The company maintained fiscal 2027 guidance of 5%-7% core constant-currency revenue growth, reported more than $1.0 billion returned to shareholders during the quarter, and declared a $0.66-per-share dividend payable December 17 to shareholders of record November 12.